• Thumbnail for Exenatide
    Exenatide, sold under the brand name Byetta among others, is a medication used to treat type 2 diabetes. It is used together with diet, exercise, and...
    24 KB (2,087 words) - 16:42, 11 May 2024
  • Thumbnail for Amylin Pharmaceuticals
    produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended release). In 1987, Amylin Pharmaceuticals was co-founded...
    14 KB (1,253 words) - 22:25, 14 August 2024
  • the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered...
    50 KB (5,222 words) - 18:06, 23 August 2024
  • Thumbnail for Gila monster
    injection. Exenatide also slows the emptying of the stomach and causes a decrease in appetite, contributing to weight loss. The antidiabetic exenatide (Byetta)...
    47 KB (5,520 words) - 14:10, 15 August 2024
  • the risk of thrombosis. It is an antagonist of glycoprotein IIb/IIIa. Exenatide is a 39-amino-acid peptide that is a synthetic version of exendin-4, a...
    11 KB (1,302 words) - 19:09, 20 November 2023
  • Thumbnail for Pancreatitis
    pancreatitis including metformin, but glucagon-like peptide-1 mimetics such as exenatide are more strongly associated with pancreatitis by promoting inflammation...
    42 KB (4,131 words) - 23:01, 5 August 2024
  • Some patients develop anti-drug antibodies, which are more common with exenatide (the antibodies were detectable in a third or more of patients) than other...
    37 KB (3,890 words) - 03:08, 12 August 2024
  • Thumbnail for Liraglutide
    with liraglutide 1.8 mg compared to insulin glargine, 0.33% more than exenatide 10 μg twice daily, sitagliptin and rosiglitazone. In a randomized controlled...
    31 KB (2,666 words) - 11:03, 12 June 2024
  • Thumbnail for Semaglutide
    suggested 1–3 years use of glucagon like peptide-1 receptor agonists like exenatide, liraglutide and dulaglutide may be linked with increased occurrence of...
    66 KB (5,432 words) - 03:10, 31 August 2024
  • S. Food and Drug Administration (FDA) has approved a treatment called Exenatide, based on the saliva of a Gila monster, to control blood sugar in patients...
    103 KB (13,035 words) - 19:03, 24 August 2024